Accomplishments in 2008 in the adjuvant treatment of colon cancer. - Wikidata - awgldk - TriplyDB

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

http://www.wikidata.org/entity/Q37468817

about

Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.

P2860

Q37000713-CB543779-F885-4F60-912C-01502C954506

P2860

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

http://www.wikidata.org/entity/Q37468817

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@en

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@nl

type

label

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@en

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@nl

prefLabel

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@en

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@nl

P1433

Q37468817-934F49BB-D908-4087-B2ED-1ABBEF64A0A2

P1476

Q37468817-61FA35F0-61EB-4FB3-A8EE-36D0EFF0AC6B

P2093

Q37468817-08E895A2-B863-4A27-87F1-C677407E43AB

Q37468817-1C92CD9B-FDB1-49A1-A997-76B954B83308

Q37468817-34646EBC-99CE-47EC-8A44-7D6F81539539

Q37468817-88EE2351-BB13-480D-B155-8E8A7B96F349

Q37468817-AF284CFD-A5C2-467C-A30D-7EEB914B7AD4

P2860

Q37468817-15BB14BE-56E4-43C2-B321-C870405BD21A

Q37468817-1B3360D2-3984-42C9-AAF3-A0B9DBFB76DB

Q37468817-2FED663A-08C2-44D4-B7CF-2C79CD790AC2

Q37468817-31D05E7E-6068-4612-9895-84C89CC6A71B

Q37468817-4F18B31E-7F22-46BC-AD75-062A7B8F0142

Q37468817-504C27C6-A82B-466E-8F05-11C72041807B

Q37468817-6857104C-EF5E-4494-8EA0-A4E0D771663D

Q37468817-79972509-50CF-4D3A-AF99-62494E5F1B57

Q37468817-82E535E8-9A4F-4722-933B-6F8C7C51BC78

Q37468817-8A12B17A-E513-4B1F-A9B6-E442FB1FEABA

P304

Q37468817-DEE74BAD-82E1-4AEC-949E-CBBF5CB39FF9

P31

Q37468817-C437E639-E249-4878-8FDD-E6FDC523C28A

P433

Q37468817-772FB0CC-1CD2-48CD-BFFA-2580D5389769

P478

Q37468817-28F5D8F3-ABC8-4976-835B-6B53FEDB2878

P50

Q37468817-95196C78-3B01-440F-A181-33D68E074028

P577

Q37468817-BCDCFAA1-4ED0-4031-BD2A-1F43CDB5834D

P698

Q37468817-BD1EC13D-2A94-4BED-B9EA-A90FCC03F5F9

P932

Q37468817-9427648D-6891-476A-B776-89E10CFBA26C

P1433

Gastrointestinal cancer research : GCR

P1476

Accomplishments in 2008 in the adjuvant treatment of colon cancer.

@en

P2093

A de Gramont

http://www.w3.org/2001/XMLSchema#string

C-H Köhne

http://www.w3.org/2001/XMLSchema#string

Claus-Henning Köhne

http://www.w3.org/2001/XMLSchema#string

J L Marshall

http://www.w3.org/2001/XMLSchema#string

John L Marshall

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Cancer statistics, 2008

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

P304

S2-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5 Supplement 2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Aimery de Gramont

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20011560

http://www.w3.org/2001/XMLSchema#string

P932

2791381

http://www.w3.org/2001/XMLSchema#string